Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2Psoriasis 1Polycystic Ovary Syndrome 1Osteoarthritis 1Neoplasms 1Esophageal Neoplasms 1Cardiovascular Diseases 1Autoimmune Diseases 1Arthritis, Rheumatoid 1

Interventions

deucravacitinib 1cabozantinib 1Vitamin D 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Platinum Compounds 1Nivolumab 1Methods 1Ipilimumab 1Interviews as Topic 1Fish Oils 1Fatty Acids, Omega-3 1Exercise 1Eicosapentaenoic Acid 1Educational Status 1Early Intervention, Educational 1Docosahexaenoic Acids 1Cholecalciferol 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Psoriasis × Fatty Acids, Omega-3 × 1 year × Clear all
NCT01351805 2025-12-03

VITAL

Brigham and Women's Hospital

Phase NA Completed
25,871 enrolled 15 charts

Arthritis, Rheumatoid, Autoimmune Diseases, Osteoarthritis, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡